Good news! Wingor Biotech's third stem cell drug has been approved for clinical trials!by alexJanuary 16, 2026May 25, 2026
Good news! The Guangxi Zhuang Autonomous Region Stem Cell Engineering Research Center, jointly applied for by Yinguan Biotechnology, has been approved and will be located at the First Affiliated Hospital of Guilin Medical University!by alexJanuary 13, 2026May 25, 2026
From "dual registration" to the first drug administration: Wingor Biotech helps Guangxi achieve a breakthrough in stem cell clinical research.by alexDecember 18, 2025May 25, 2026
The Guangxi Cell Therapy Professional Committee was established! Wingor Biotech showcased its technological foresight at the first academic exchange conference.by alexDecember 1, 20252026年5月24日
Senior executives from Indonesian state-owned pharmaceutical company PT Bio Farma visited Innovent Biologics.by alexNovember 26, 2025May 25, 2026
Technological Innovation | Ingloun Biotechnology's "An Adaptive Cell Thawing Method and System Based on Multi-Parameter Feedback" Receives National Invention Patentby alexNovember 19, 2025May 25, 2026
At the forefront! The Medical Director of Ingenics shares clinical progress of WG103 stem cell injection for stroke treatment | 14th Beijing Cell Biology Industry Conferenceby alexNovember 14, 2025May 25, 2026
Experts from Ingenics Biotechnology were invited to attend the 3rd Greater Bay Area Cell and Gene Therapy Development Forum 2025 and deliver a keynote speech.by alexNovember 12, 2025May 25, 2026
Inglos Biopharma presents "Exploring the Commercialization Path of Cell Therapy: Drugs vs. New Biomedical Technologies" | 2025 Hainan Cell Therapy Conferenceby alexNovember 2, 2025May 25, 2026
Inglos Biopharma reports positive clinical data on MSC therapy for stroke | IGC 2025 10th Annual Conference on Cell and Derivative Research and Industrializationby alexOctober 31, 2025May 25, 2026
